Nugent, Helen Marie,Edelman, Elazer,Bollinger, Steve
申请号：
AU2010249280
公开号：
AU2010249280B2
申请日:
2010.12.10
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2010249280B220121018.pdf#####ABSTRACT The disclosed invention is based on the discovery that a cellbased therapy can be used to treat, ameliorate, manage and/or 5 reduce the progression of clinical sequelae associated with vascular interventions or cardiovascular diseases, particularly occlusive thrombosis, restenosis, intimal hyperplasia, inflammation and vasodilation. The invention further benefits from the additional discovery that a heretofore undescribed 10 implantable flowable composition is capable of sustaining a confluent population of sufficiently viable cells which can be effectively administered via a minimally-invasive surgical procedure without diminishing the clinical effectiveness or the viability of the cells. The disclosed invention can be used to 15 treat vasculature as well as non-vascular tubular structures such as a fallopian tube. 24907531 (GHMatters) 10/12110WO 2006/062871 PCT/US2005/043844 FIG. 1 15 0 x 10 E S 5 z 0 0 5 10 15 20 Days
